Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cell Death and Differentiation|February 11, 2017
EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitorsPolina Zjablovskaja, Miroslava Kardosova, Petr Danek, et al.
Cell Death & Disease|July 28, 2018
MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemiaJens-Uwe Hartmann, Daniela Bräuer-Hartmann, Miroslava Kardosova, et al.
International Journal of Cancer|December 11, 2023
BRAF and MEK inhibitor combinations induce potent molecular and immunological effects in NRAS-mutant melanoma cells: Insights into mode of action and resistance mechanismsLisa Dinter, Paula C Karitzky, Alexander Schulz, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 4, 2025
A quiescence-like/TGF-β1-specific CRISPRi screen reveals drug uptake transporters as secondary targets of kinase inhibitors in AMLElahe Rahimian, Masoud Koochak, Sofia Traikov, et al.
Developmental Cell|October 27, 2023
Choroid plexuses carry nodal-like cilia that undergo axoneme regression from early adult stageKim Hoa Ho, Adrien Candat, Valentina Scarpetta, et al.
Cell Reports|February 19, 2026
ACSL4-associated lipid metabolism is a distinct therapeutic vulnerability in KMT2A-rearranged acute myeloid leukemiaSilvia Schäfer, Elahe Rahimian, Lola Schmitz-Hübsch, et al.
Leukemia|May 22, 2021
The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decisionFriederike Herbst, Tonio J L Lang, Elias S P Eckert, et al.
Cell Reports. Medicine|September 21, 2023
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivityAlexander A Wurm, Silke Brilloff, Sofia Kolovich, et al.
Cell Discovery|June 11, 2024
Clathrin mediates membrane fission and budding by constricting membrane poresLisi Wei, Xiaoli Guo, Ehud Haimov, et al.
Blood Neoplasia|June 22, 2026
Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interferenceMarta Lustig, Maja Kowol, Alina M Hartmann, et al.
Pageof 8